Models for Predicting IKKA and IKKB blockade

Journal of Chemical Information and Modeling

Volumn 52, Issue 12, 2012, Pages 3190-3199

  Hu, Haipeng ^a   Snyder, James P ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTATIONAL CHEMISTRY; ENZYMES; MOLECULAR GRAPHICS; SULFUR COMPOUNDS;

COMPLEX STRUCTURE; CRYSTALLINE STATE; HIGHLY ACCURATE; HOMOLOGY MODELING; QSAR MODEL; TYPE II KINASE INHIBITOR; X-RAY STRUCTURE;

CRYSTAL STRUCTURE;

I KAPPA B KINASE; PROTEIN KINASE INHIBITOR;

ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG DATABASE; DRUG DEVELOPMENT; METABOLISM; METHODOLOGY; MOLECULAR DOCKING; PROTEIN CONFORMATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; DATABASES, PHARMACEUTICAL; DRUG DISCOVERY; I-KAPPA B KINASE; MOLECULAR DOCKING SIMULATION; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84871534763     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci300287t     Document Type: Article

References (46)

1. Strnad, J.; Burke, J. R. IkappaB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges Trends Pharmacol. Sci. 2007, 28, 142-148
2. Zandi, E.; Rothwarf, D. M.; Delhase, M.; Hayakawa, M.; Karin, M. The IKB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKA and IKKB, Necessary for IK B Phosphorylation and NF- KB Activation Cell 1997, 91, 243-252
3. Ghosh, S.; Karin, M.; Haven, N. Missing Pieces in the NF-κB Puzzle Cell 2002, 109, S81-96
4. Burke, J. R.; Pattoli, M. a; Gregor, K. R.; Brassil, P. J.; MacMaster, J. F.; McIntyre, K. W.; Yang, X.; Iotzova, V. S.; Clarke, W.; Strnad, J.; Qiu, Y.; Zusi, F. C. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice J. Biol. Chem. 2003, 278, 1450-1456
5. Ziegelbauer, K.; Gantner, F.; Lukacs, N. W.; Berlin, A.; Fuchikami, K.; Niki, T.; Sakai, K.; Inbe, H.; Takeshita, K.; Ishimori, M.; Komura, H.; Murata, T.; Lowinger, T.; Bacon, K. B. A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity Br. J. Pharmacol. 2005, 145, 178-192
6. Liu, T.; Lin, Y.; Wen, X.; Jorissen, R. N.; Gilson, M. K. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities Nucleic Acids Res. 2007, 35, D198-201
7. Eswar, N.; Eramian, D.; Webb, B.; Shen, M.-yi; Sali, A. Protein structure modeling with MODELLER Methods Mol. Biol. 2008, 426, 145-59
8. Prime, version 3.1; Schrödinger, LLC, New York, 2012.
9. Glide, version 5.8; Schrödinger, LLC, New York, 2012.
10. Hopfield, J. J. Neural networks and physical systems with emergent collective computational abilities Proc. Nat. Acad. Sci. 1982, 79, 2554-2558
11. Canvas, version 1.4; Schrödinger, LLC, New York, 2011.
12. Phase, version 3.3; Schrödinger, LLC, New York, 2011.
13. Tetko, I. V.; Livingstone, D. J.; Luik, A. I. Neural network studies. 1. Comparison of overfitting and overtraining J. Chem. Inf. Comput. Sci. 1995, 35, 826-833
14. Castro, A. C.; Dang, L. C.; Soucy, F.; Grenier, L.; Mazdiyasni, H.; Hottelet, M.; Parent, L.; Pien, C.; Palombella, V.; Adams, J.; Novel, I. K. K. inhibitors: β-carbolines Bioorg. Med. Chem. Lett. 2003, 13, 2419-2422
15. Bingham, A. H.; Davenport, R. J.; Gowers, L.; Knight, R. L.; Lowe, C.; Owen, D. a.; Parry, D. M.; Pitt, W. R. A novel series of potent and selective IKK2 inhibitors Bioorg. Med. Chem. Lett. 2004, 14, 409-412
16. Murata, T.; Shimada, M.; Kadono, H.; Sakakibara, S.; Yoshino, T.; Masuda, T.; Shimazaki, M.; Shintani, T.; Fuchikami, K.; Bacon, K. B.; Ziegelbauer, K. B.; Lowinger, T. B. Synthesis and structure-activity relationships of novel IKK-beta inhibitors. Part 2: Improvement of in vitro activity Bioorg. Med. Chem. Lett. 2004, 14, 4013-4017
17. Murata, T.; Shimada, M.; Sakakibara, S.; Yoshino, T.; Masuda, T.; Shintani, T.; Sato, H.; Koriyama, Y.; Fukushima, K.; Nunami, N.; Yamauchi, M.; Fuchikami, K.; Komura, H.; Watanabe, A.; Ziegelbauer, K. B.; Bacon, K. B.; Lowinger, T. B. Synthesis and structure-activity relationships of novel IKK-beta inhibitors. Part 3: Orally active anti-inflammatory agents Bioorg. Med. Chem. Lett. 2004, 14, 4019-4022
18. Bonafoux, D.; Bonar, S.; Christine, L.; Clare, M.; Donnelly, A.; Guzova, J.; Kishore, N.; Lennon, P.; Libby, A.; Mathialagan, S.; McGhee, W.; Rouw, S.; Sommers, C.; Tollefson, M.; Tripp, C.; Weier, R.; Wolfson, S.; Min, Y. Inhibition of IKK-2 by 2-[(aminocarbonyl)amino]-5-acetylenyl-3-thiophenecarbox- amides Bioorg. Med. Chem. Lett. 2005, 14, 2870-2875
19. Waelchli, R.; Bollbuck, B.; Bruns, C.; Buhl, T.; Eder, J.; Feifel, R.; Hersperger, R.; Janser, P.; Revesz, L.; Zerwes, H. G.; Schlapbach, A. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK Bioorg. Med. Chem. Lett. 2006, 16, 108-112
20. Morwick, T.; Berry, A.; Brickwood, J.; Cardozo, M.; Catron, K.; DeTuri, M.; Emeigh, J.; Homon, C.; Hrapchak, M.; Jacober, S.; Kaplita, P.; Kelly, T. A.; Ksiazek, J.; Liuzzi, M.; Magolda, R.; Mao, C.; Marshall, D.; McNeil, D.; Prokopowicz, A., 3rd; Sarko, C.; Scouten, E.; Sledziona, C.; Sun, S.; Watrous, J.; Wu, J. P.; Cywin, C. L Evolution of the thienopyridine class of inhibitors of IkappaB kinase-beta: part I: hit-to-lead strategies J. Med. Chem. 2006, 49, 2898-2908
21. Bain, J.; Plater, L.; Elliott, M.; Shpiro, N.; Hastie, C. J.; McLauchlan, H.; Klevernic, I.; Arthur, J. S. C.; Alessi, D. R.; Cohen, P. The selectivity of protein kinase inhibitors: a further update Biophys. J. 2007, 408, 297-315
22. Beaulieu, F.; Ouellet, C.; Ruediger, E. H.; Belema, M.; Qiu, Y.; Yang, X.; Banville, J.; Burke, J. R.; Gregor, K. R.; MacMaster, J. F.; Martel, A.; Mclntyre, K. W.; Pattoli, M. A.; Zusi, F. C.; Vyas, D. Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors Bioorg. Med. Chem. Lett. 2007, 17, 1233-1237
23. Christopher, J. a; Avitabile, B. G.; Bamborough, P.; Champigny, A. C.; Cutler, G. J.; Dyos, S. L.; Grace, K. G.; Kerns, J. K.; Kitson, J. D.; Mellor, G. W.; Morey, J. V.; Morse, M. A.; O'Malley, C. F.; Patel, C. B.; Probst, N.; Rumsey, W.; Smith, C. A.; Wilson, M. J. The discovery of 2-amino-3,5- diarylbenzamide inhibitors of IKK-alpha and IKK-beta kinases Bioorg. Med. Chem. Lett. 2007, 17, 3972-3977
24. Belema, M.; Bunker, A.; Nguyen, V. N.; Beaulieu, F.; Ouellet, C.; Qiu, Y.; Zhang, Y.; Martel, A.; Burke, J. R.; Mclntyre, K. W.; Pattoli, M. A.; Daloisio, C.; Gillooly, K. M.; Clarke, W. J.; Brassil, P. J.; Zusi, F. C.; Vyas, D. M. Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3, 2-e) pyrazines as IKK-beta inhibitors Bioorg. Med. Chem. Lett. 2007, 17, 4284-4289
25. Bamborough, P.; Drewry, D.; Harper, G.; Smith, G. K.; Schneider, K. Assessment of chemical coverage of kinome space and its implications for kinase drug discovery J. Med. Chem. 2008, 51, 7898-7914
26. Christopher, J. a; Bamborough, P.; Alder, C.; Campbell, A.; Cutler, G. J.; Down, K.; Hamadi, A. M.; Jolly, A. M.; Kerns, J. K.; Lucas, F. S.; Mellor, G. W.; Miller, D. D.; Morse, M. A.; Pancholi, K. D.; Rumsey, W.; Solanke, Y. E.; Williamson, R. Discovery of 6-aryl-7-alkoxyisoquinoline inhibitors of IkappaB kinase-beta (IKK-beta) J. Med. Chem. 2009, 52, 3098-3102
27. Kempson, J.; Guo, J.; Das, J.; Moquin, R. V.; Spergel, S. H.; Watterson, S. H.; Langevine, C. M.; Dyckman, A. J.; Pattoli, M.; Burke, J. R.; Yang, X. X.; Gillooly, K. M.; Mclntyre, K. W.; Chen, L.; Dodd, J. H.; McKinnon, M.; Barrish, J. C.; Pitts, W. J. Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase Bioorg. Med. Chem. Lett. 2009, 19, 2646-2649
28. Nagarajan, S.; Doddareddy, M. R.; Choo, H.; Cho, Y. S.; Oh, K.-S.; Lee, B. H.; Pae, A. N. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening Bioorg. Med. Chem. 2009, 17, 2759-2766
29. Nagarajan, S.; Doddareddy, M. R.; Choo, H.; Cho, Y. S.; Oh, K.-S.; Lee, B. H.; Pae, A. N. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening Bioorg. Med. Chem. 2009, 17, 2759-2766
30. Nagarajan, S.; Choo, H.; Cho, Y. S.; Oh, K.-S.; Lee, B. H.; Shin, K. J.; Pae, A. N. IKKbeta inhibitors identification part II: ligand and structure-based virtual screening Bioorg. Med. Chem. 2010, 18, 3951-3960
31. Bonafoux, D. F.; Bonar, S. L.; Clare, M.; Donnelly, A. M.; Glaenzer, J. L.; Guzova, J. a; Huang, H.; Kishore, N.N.; Koszyk, F.J.; Lennon, P. J.; Libby, A.; Mathialagan, S.; Oburn, D. S.; Rouw, S. A.; Sommers, C. D.; Tripp, C. S.; Vanella, L. J.; Weier, R.; Wolfson, S. G.; Huang, H. C. Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship Bioorg. Med. Chem. 2010, 18, 403-414
32. Bhattarai, B. R.; Ko, J.-H.; Shrestha, S.; Kafle, B.; Cho, H.; Kang, J.-H.; Cho, H. Inhibition of IKK-beta: a new development in the mechanism of the anti-obesity effects of PTP1B inhibitors SA18 and SA32 Bioorg. Med. Chem. Lett. 2010, 20, 1075-1077
33. Crombie, A. L.; Sum, F.-W.; Powell, D. W.; Hopper, D. W.; Torres, N.; Berger, D. M.; Zhang, Y.; Cavriil, M.; Sadler, T. M.; Arndt, K. Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKbeta inhibitors Bioorg. Med. Chem. Lett. 2010, 20, 3821-3825
34. Shimizu, H.; Tanaka, S.; Toki, T.; Yasumatsu, I.; Akimoto, T.; Morishita, K.; Yamasaki, T.; Yasukochi, T.; Iimura, S. Discovery of imidazo[1,2-b] pyridazine derivatives as IKKbeta inhibitors. Part 1: Hit-to-lead study and structure-activity relationship Bioorg. Med. Chem. Lett. 2010, 20, 5113-5118
35. Noha, S. M.; Atanasov, A. G.; Schuster, D.; Markt, P.; Fakhrudin, N.; Heiss, E. H.; Schrammel, O.; Rollinger, J. M.; Stuppner, H.; Dirsch, V. M.; Wolber, G. Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques Bioorg. Med. Chem. Lett. 2011, 21, 577-583
36. Xie, J.; Poda, G. I.; Hu, Y.; Chen, N. X.; Heier, R. F.; Wolfson, S. G.; Reding, M. T.; Lennon, P. J.; Kurumbail, R. G.; Selness, S. R.; Li, X.; Kishore, N. N; Sommers, C. D.; Christine, L.; Bonar, S. L.; Venkatraman, N.; Mathialagan, S.; Brustkern, S. J.; Huang, H. C. Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure-activity relationship Bioorg. Med. Chem. 2011, 19, 1242-1255
37. Dyckman, A. J.; Langevine, C. M.; Quesnelle, C.; Kempson, J.; Guo, J.; Gill, P.; Spergel, S. H.; Watterson, S. H.; Li, T.; Nirschl, D. S.; Gillooly, K. M.; Pattoli, M. A.; Mclntyre, K. W.; Chen, L.; McKinnon, M.; Dood, J. H.; Barrish, J. C.; Burke, J. R.; Pitts, W. J. Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis Bioorg. Med. Chem. Lett. 2011, 21, 383-386
38. Shimizu, H.; Yasumatsu, I.; Hamada, T.; Yoneda, Y.; Yamasaki, T.; Tanaka, S.; Toki, T.; Yokoyama, M.; Morishita, K.; Iimura, S. Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 2: improvement of potency in vitro and in vivo Bioorg. Med. Chem. Lett. 2011, 21, 904-908
39. Takahashi, H.; Shinoyama, M.; Komine, T.; Nagao, M.; Suzuki, M.; Tsuchida, H.; Katsuyama, K. Novel dihydrothieno[2,3- e ]indazole derivatives as IκB kinase inhibitors Bioorg. Med. Chem. Lett. 2011, 21, 1758-1762
40. Avila, C. M.; Lopes, A. B.; GoncÌalves, A. S.; da Silva, L. L.; Romeiro, N. C.; Miranda, A. L. P.; Sant'Anna, C. M. R.; Barreiro, E. J.; Fraga, C. a M. Structure-based design and biological profile of (E)- N -(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IκB kinase-β Eur. J. Med. Chem. 2011, 46, 1245-1253
41. Kempson, J.; Spergel, S. H.; Guo, J.; Quesnelle, C.; Gill, P.; Belanger, D.; Dyckman, A. J.; Li, T.; Watterson, S. H.; Langevine, C. M.; Das, J.; Moquin, R. V.; Furch, J. A.; Marinier, A.; Dodier, M.; Martel, A.; Nirschl, D.; VanKirk, K.; Burke, J. R.; Pattoli, M. A.; Gillooly, K.; McIntyre, K. W.; Chen, L.; Yang, Z.; Marathe, P. H.; Wang-Iverson, D.; Dodd, J. H.; McKinnon, M.; Barrish, J. C.; Pitts, W. J. Novel tricyclic inhibitors of IkappaB kinase J. Med. Chem. 2009, 52, 1994-2005
42. LigPrep, version 2.5; Schrödinger, LLC, New York, 2011.
43. Irina, K.; Ruben, A. Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states J. Med. Chem. 2008, 51, 7921-7932
44. Xu, G.; Lo, Y. C.; Li, Q.; Napolitano, G.; Wu, X.; Jiang, X.; Dreano, M.; Karin, M.; Wu, H. Crystal structure of inhibitor of κB kinase β (IKKβ) Nature 2011, 21, 325-330
45. Larkin, M. a; Blackshields, G.; Brown, N. P.; Chenna, R.; McGettigan, P. a; McWilliam, H.; Valentin, F.; Wallace, I. M.; Wilm, a; Lopez, R.; Thompson, J. D.; Gibson, T. J.; Higgins, D. G. Clustal W. and Clustal X. version 2.0 Bioinformatics 2007, 23, 2947-2948
46. Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.; Thornton, J. M. PROCHECK: a program to check the stereo chemical quality of protein structures J. Appl. Crystallogr. 1993, 26, 283-291